home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Genetic News | search  
 

BCL11A: a pathologic target gene in lymphoid malignancies

 
  December, 3 2001 9:32
your information resource in human molecular genetics
 
     
Amplifications of a region of chromosome 2p13 have been observed in various B-cell malignancies. After having ruled out several candidate genes, British, German and US researchers were able to identify the BCL11A gene and its 3 major RNA isoforms as the pathologic target for the amplification (Blood. 2001 Dec 1; 98(12):3413-3420). The researchers also reported that a previously identified translocation may contribute to deregulation of the BCL11A locus.

Contact :
P. W. Tucker
University of Texas at Austin, ESB 534, 100W 24th St,
Austin, TX 78705
E-mail: philtucker@mail.utexas.edu
or
Martin J. S. Dyer
Department of Haematology, University of Leicester
PO Box 65, Leicester, LE2 7LX, UK
E-mail: mjsd1@le.ac.uk.


Message posted by: Ulrike Sattler

print this article mail this article
Bookmark and Share this page (what is this?)

Social bookmarking allows users to save and categorise a personal collection of bookmarks and share them with others. This is different to using your own browser bookmarks which are available using the menus within your web browser.

Use the links below to share this article on the social bookmarking site of your choice.

Read more about social bookmarking at Wikipedia - Social Bookmarking

Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2016 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.